Acme United Corporation (ACU) Stock Competitors & Peer Comparison
See (ACU) competitors and their performances in Stock Market.
Peer Comparison Table: Household & Personal Products Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ACU | $47.66 | +0.21% | 185.5M | 20.99 | $2.32 | +1.35% |
| PG | $147.73 | -0.52% | 347B | 21.47 | $6.94 | +2.85% |
| UL | $60.52 | -0.04% | 130.6B | 19.94 | $3.04 | +3.75% |
| CL | $91.84 | +0.86% | 73.6B | 24.54 | $3.75 | +2.29% |
| KVUE | $19.00 | +0.21% | 36.7B | 16.49 | $1.16 | +4.35% |
| KMB | $108.80 | +0.65% | 36.3B | 18.03 | $6.07 | +4.65% |
| EL | $79.03 | -3.03% | 29.1B | 36.40 | $2.21 | +1.75% |
| CHD | $97.26 | -0.91% | 23.6B | 27.94 | $3.56 | +1.22% |
| SGI | $77.47 | -1.43% | 16.4B | 27.95 | $2.79 | +0.82% |
| CLX | $96.31 | +1.09% | 11.8B | 14.45 | $6.75 | +5.10% |
Stock Comparison
ACU vs PG Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 185.5M. In comparison, PG has a market cap of 347B. Regarding current trading prices, ACU is priced at $47.66, while PG trades at $147.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 20.99, whereas PG's P/E ratio is 21.47. In terms of profitability, ACU's ROE is +0.08%, compared to PG's ROE of +0.31%. Regarding short-term risk, ACU is more volatile compared to PG. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check PG's competition here
ACU vs UL Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 185.5M. In comparison, UL has a market cap of 130.6B. Regarding current trading prices, ACU is priced at $47.66, while UL trades at $60.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 20.99, whereas UL's P/E ratio is 19.94. In terms of profitability, ACU's ROE is +0.08%, compared to UL's ROE of +0.36%. Regarding short-term risk, ACU is more volatile compared to UL. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check UL's competition here
ACU vs CL Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 185.5M. In comparison, CL has a market cap of 73.6B. Regarding current trading prices, ACU is priced at $47.66, while CL trades at $91.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 20.99, whereas CL's P/E ratio is 24.54. In terms of profitability, ACU's ROE is +0.08%, compared to CL's ROE of +4.75%. Regarding short-term risk, ACU is more volatile compared to CL. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check CL's competition here
ACU vs KVUE Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 185.5M. In comparison, KVUE has a market cap of 36.7B. Regarding current trading prices, ACU is priced at $47.66, while KVUE trades at $19.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 20.99, whereas KVUE's P/E ratio is 16.49. In terms of profitability, ACU's ROE is +0.08%, compared to KVUE's ROE of +0.15%. Regarding short-term risk, ACU is more volatile compared to KVUE. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check KVUE's competition here
ACU vs KMB Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 185.5M. In comparison, KMB has a market cap of 36.3B. Regarding current trading prices, ACU is priced at $47.66, while KMB trades at $108.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 20.99, whereas KMB's P/E ratio is 18.03. In terms of profitability, ACU's ROE is +0.08%, compared to KMB's ROE of +1.44%. Regarding short-term risk, ACU is more volatile compared to KMB. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check KMB's competition here
ACU vs EL Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 185.5M. In comparison, EL has a market cap of 29.1B. Regarding current trading prices, ACU is priced at $47.66, while EL trades at $79.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 20.99, whereas EL's P/E ratio is 36.40. In terms of profitability, ACU's ROE is +0.08%, compared to EL's ROE of -0.06%. Regarding short-term risk, ACU is less volatile compared to EL. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check EL's competition here
ACU vs CHD Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 185.5M. In comparison, CHD has a market cap of 23.6B. Regarding current trading prices, ACU is priced at $47.66, while CHD trades at $97.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 20.99, whereas CHD's P/E ratio is 27.94. In terms of profitability, ACU's ROE is +0.08%, compared to CHD's ROE of +0.17%. Regarding short-term risk, ACU is more volatile compared to CHD. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check CHD's competition here
ACU vs SGI Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 185.5M. In comparison, SGI has a market cap of 16.4B. Regarding current trading prices, ACU is priced at $47.66, while SGI trades at $77.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 20.99, whereas SGI's P/E ratio is 27.95. In terms of profitability, ACU's ROE is +0.08%, compared to SGI's ROE of +0.17%. Regarding short-term risk, ACU is more volatile compared to SGI. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check SGI's competition here
ACU vs CLX Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 185.5M. In comparison, CLX has a market cap of 11.8B. Regarding current trading prices, ACU is priced at $47.66, while CLX trades at $96.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 20.99, whereas CLX's P/E ratio is 14.45. In terms of profitability, ACU's ROE is +0.08%, compared to CLX's ROE of +28.26%. Regarding short-term risk, ACU is more volatile compared to CLX. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check CLX's competition here
ACU vs REYN Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 185.5M. In comparison, REYN has a market cap of 5.7B. Regarding current trading prices, ACU is priced at $47.66, while REYN trades at $26.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 20.99, whereas REYN's P/E ratio is 15.98. In terms of profitability, ACU's ROE is +0.08%, compared to REYN's ROE of +0.15%. Regarding short-term risk, ACU is more volatile compared to REYN. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check REYN's competition here
ACU vs NTCO Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 185.5M. In comparison, NTCO has a market cap of 4.6B. Regarding current trading prices, ACU is priced at $47.66, while NTCO trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 20.99, whereas NTCO's P/E ratio is -11.37. In terms of profitability, ACU's ROE is +0.08%, compared to NTCO's ROE of -0.15%. Regarding short-term risk, ACU is more volatile compared to NTCO. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check NTCO's competition here
ACU vs ELF Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 185.5M. In comparison, ELF has a market cap of 4B. Regarding current trading prices, ACU is priced at $47.66, while ELF trades at $67.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 20.99, whereas ELF's P/E ratio is 21.55. In terms of profitability, ACU's ROE is +0.08%, compared to ELF's ROE of +0.02%. Regarding short-term risk, ACU is less volatile compared to ELF. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check ELF's competition here
ACU vs IPAR Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 185.5M. In comparison, IPAR has a market cap of 3.5B. Regarding current trading prices, ACU is priced at $47.66, while IPAR trades at $105.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 20.99, whereas IPAR's P/E ratio is 20.49. In terms of profitability, ACU's ROE is +0.08%, compared to IPAR's ROE of +0.19%. Regarding short-term risk, ACU is less volatile compared to IPAR. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check IPAR's competition here
ACU vs NWL Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 185.5M. In comparison, NWL has a market cap of 2.5B. Regarding current trading prices, ACU is priced at $47.66, while NWL trades at $5.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 20.99, whereas NWL's P/E ratio is 10.78. In terms of profitability, ACU's ROE is +0.08%, compared to NWL's ROE of -0.11%. Regarding short-term risk, ACU is less volatile compared to NWL. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check NWL's competition here
ACU vs SPB Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 185.5M. In comparison, SPB has a market cap of 2B. Regarding current trading prices, ACU is priced at $47.66, while SPB trades at $85.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 20.99, whereas SPB's P/E ratio is 13.44. In terms of profitability, ACU's ROE is +0.08%, compared to SPB's ROE of +0.07%. Regarding short-term risk, ACU is more volatile compared to SPB. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check SPB's competition here
ACU vs COTY Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 185.5M. In comparison, COTY has a market cap of 1.7B. Regarding current trading prices, ACU is priced at $47.66, while COTY trades at $1.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 20.99, whereas COTY's P/E ratio is 10.64. In terms of profitability, ACU's ROE is +0.08%, compared to COTY's ROE of -0.15%. Regarding short-term risk, ACU is less volatile compared to COTY. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check COTY's competition here
ACU vs EPC Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 185.5M. In comparison, EPC has a market cap of 1.3B. Regarding current trading prices, ACU is priced at $47.66, while EPC trades at $27.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 20.99, whereas EPC's P/E ratio is 13.60. In terms of profitability, ACU's ROE is +0.08%, compared to EPC's ROE of -0.05%. Regarding short-term risk, ACU is less volatile compared to EPC. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check EPC's competition here
ACU vs HELE Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 185.5M. In comparison, HELE has a market cap of 660.1M. Regarding current trading prices, ACU is priced at $47.66, while HELE trades at $27.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 20.99, whereas HELE's P/E ratio is 8.02. In terms of profitability, ACU's ROE is +0.08%, compared to HELE's ROE of -0.95%. Regarding short-term risk, ACU is less volatile compared to HELE. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check HELE's competition here
ACU vs EWCZ Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 185.5M. In comparison, EWCZ has a market cap of 319.1M. Regarding current trading prices, ACU is priced at $47.66, while EWCZ trades at $5.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 20.99, whereas EWCZ's P/E ratio is 29.10. In terms of profitability, ACU's ROE is +0.08%, compared to EWCZ's ROE of +0.10%. Regarding short-term risk, ACU is more volatile compared to EWCZ. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check EWCZ's competition here
ACU vs NUS Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 185.5M. In comparison, NUS has a market cap of 255.1M. Regarding current trading prices, ACU is priced at $47.66, while NUS trades at $5.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 20.99, whereas NUS's P/E ratio is 4.38. In terms of profitability, ACU's ROE is +0.08%, compared to NUS's ROE of +0.07%. Regarding short-term risk, ACU is less volatile compared to NUS. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check NUS's competition here
ACU vs PTNM Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 185.5M. In comparison, PTNM has a market cap of 207.9M. Regarding current trading prices, ACU is priced at $47.66, while PTNM trades at $10.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 20.99, whereas PTNM's P/E ratio is 346.33. In terms of profitability, ACU's ROE is +0.08%, compared to PTNM's ROE of -0.05%. Regarding short-term risk, ACU is more volatile compared to PTNM. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check PTNM's competition here
ACU vs SKIN Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 185.5M. In comparison, SKIN has a market cap of 85.5M. Regarding current trading prices, ACU is priced at $47.66, while SKIN trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 20.99, whereas SKIN's P/E ratio is -3.88. In terms of profitability, ACU's ROE is +0.08%, compared to SKIN's ROE of -0.09%. Regarding short-term risk, ACU is less volatile compared to SKIN. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check SKIN's competition here
ACU vs SLSN Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 185.5M. In comparison, SLSN has a market cap of 64.3M. Regarding current trading prices, ACU is priced at $47.66, while SLSN trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 20.99, whereas SLSN's P/E ratio is 73.99. In terms of profitability, ACU's ROE is +0.08%, compared to SLSN's ROE of +0.05%. Regarding short-term risk, ACU is less volatile compared to SLSN. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check SLSN's competition here
ACU vs GROV Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 185.5M. In comparison, GROV has a market cap of 53.8M. Regarding current trading prices, ACU is priced at $47.66, while GROV trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 20.99, whereas GROV's P/E ratio is -4.92. In terms of profitability, ACU's ROE is +0.08%, compared to GROV's ROE of -1.06%. Regarding short-term risk, ACU is less volatile compared to GROV. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check GROV's competition here
ACU vs AXIL Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 185.5M. In comparison, AXIL has a market cap of 40.1M. Regarding current trading prices, ACU is priced at $47.66, while AXIL trades at $6.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 20.99, whereas AXIL's P/E ratio is 49.04. In terms of profitability, ACU's ROE is +0.08%, compared to AXIL's ROE of +0.09%. Regarding short-term risk, ACU is less volatile compared to AXIL. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check AXIL's competition here
ACU vs UG Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 185.5M. In comparison, UG has a market cap of 32.9M. Regarding current trading prices, ACU is priced at $47.66, while UG trades at $7.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 20.99, whereas UG's P/E ratio is 13.77. In terms of profitability, ACU's ROE is +0.08%, compared to UG's ROE of +0.21%. Regarding short-term risk, ACU is less volatile compared to UG. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check UG's competition here
ACU vs DSY Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 185.5M. In comparison, DSY has a market cap of 13.3M. Regarding current trading prices, ACU is priced at $47.66, while DSY trades at $2.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 20.99, whereas DSY's P/E ratio is -0.31. In terms of profitability, ACU's ROE is +0.08%, compared to DSY's ROE of +14.77%. Regarding short-term risk, ACU is less volatile compared to DSY. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check DSY's competition here
ACU vs PHH Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 185.5M. In comparison, PHH has a market cap of 10M. Regarding current trading prices, ACU is priced at $47.66, while PHH trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 20.99, whereas PHH's P/E ratio is -0.53. In terms of profitability, ACU's ROE is +0.08%, compared to PHH's ROE of +0.38%. Regarding short-term risk, ACU is less volatile compared to PHH. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check PHH's competition here
ACU vs MTEX Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 185.5M. In comparison, MTEX has a market cap of 9.8M. Regarding current trading prices, ACU is priced at $47.66, while MTEX trades at $5.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 20.99, whereas MTEX's P/E ratio is -0.75. In terms of profitability, ACU's ROE is +0.08%, compared to MTEX's ROE of -23.83%. Regarding short-term risk, ACU is less volatile compared to MTEX. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check MTEX's competition here
ACU vs BRSH Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 185.5M. In comparison, BRSH has a market cap of 8.7M. Regarding current trading prices, ACU is priced at $47.66, while BRSH trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 20.99, whereas BRSH's P/E ratio is -0.01. In terms of profitability, ACU's ROE is +0.08%, compared to BRSH's ROE of +1.19%. Regarding short-term risk, ACU is less volatile compared to BRSH. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check BRSH's competition here
ACU vs TANH Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 185.5M. In comparison, TANH has a market cap of 2.4M. Regarding current trading prices, ACU is priced at $47.66, while TANH trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 20.99, whereas TANH's P/E ratio is 0.04. In terms of profitability, ACU's ROE is +0.08%, compared to TANH's ROE of -0.25%. Regarding short-term risk, ACU is more volatile compared to TANH. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check TANH's competition here
ACU vs TKLF Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 185.5M. In comparison, TKLF has a market cap of 842.3K. Regarding current trading prices, ACU is priced at $47.66, while TKLF trades at $2.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 20.99, whereas TKLF's P/E ratio is 33.17. In terms of profitability, ACU's ROE is +0.08%, compared to TKLF's ROE of +0.17%. Regarding short-term risk, ACU is less volatile compared to TKLF. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check TKLF's competition here
ACU vs BRSHW Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 185.5M. In comparison, BRSHW has a market cap of 6.1K. Regarding current trading prices, ACU is priced at $47.66, while BRSHW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 20.99, whereas BRSHW's P/E ratio is N/A. In terms of profitability, ACU's ROE is +0.08%, compared to BRSHW's ROE of +1.19%. Regarding short-term risk, ACU is less volatile compared to BRSHW. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check BRSHW's competition here
ACU vs RDEN Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 185.5M. In comparison, RDEN has a market cap of 0. Regarding current trading prices, ACU is priced at $47.66, while RDEN trades at $13.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 20.99, whereas RDEN's P/E ratio is N/A. In terms of profitability, ACU's ROE is +0.08%, compared to RDEN's ROE of -0.77%. Regarding short-term risk, ACU is more volatile compared to RDEN. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check RDEN's competition here
ACU vs GROV-WT Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 185.5M. In comparison, GROV-WT has a market cap of 0. Regarding current trading prices, ACU is priced at $47.66, while GROV-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 20.99, whereas GROV-WT's P/E ratio is N/A. In terms of profitability, ACU's ROE is +0.08%, compared to GROV-WT's ROE of -1.06%. Regarding short-term risk, ACU is more volatile compared to GROV-WT. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check GROV-WT's competition here
ACU vs REV Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 185.5M. In comparison, REV has a market cap of 0. Regarding current trading prices, ACU is priced at $47.66, while REV trades at $3.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 20.99, whereas REV's P/E ratio is -1.19. In terms of profitability, ACU's ROE is +0.08%, compared to REV's ROE of +0.89%. Regarding short-term risk, ACU is less volatile compared to REV. This indicates potentially lower risk in terms of short-term price fluctuations for ACU.Check REV's competition here
ACU vs SUMR Comparison July 2026
ACU plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACU stands at 185.5M. In comparison, SUMR has a market cap of 0. Regarding current trading prices, ACU is priced at $47.66, while SUMR trades at $11.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACU currently has a P/E ratio of 20.99, whereas SUMR's P/E ratio is -3.66. In terms of profitability, ACU's ROE is +0.08%, compared to SUMR's ROE of -0.75%. Regarding short-term risk, ACU is more volatile compared to SUMR. This indicates potentially higher risk in terms of short-term price fluctuations for ACU.Check SUMR's competition here